ArticleHeliyon2023
Adsorption efficacy of functionalized Cu-BDC MOFs tethered 2-mercaptobenzimidazole analogue: A comparative study.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 16 citations in OpenAlex.
- Valorization of domestic wastes into Cu-MOF-derived CuO@ZnO nanocomposites for sustainable photocatalytic degradation of methylene blue and rhodamine B dyes.Scientific reports · 2026Article
- Nonlinear kinetics, isotherms, and thermodynamic approach in the carcinogenic ions elimination by MnScientific reports · 2025Article
- Synthesis of Magnetically Modified Copper-Based Metal-Organic Frameworks for Cellulose Hydrolysis.ACS omega · 2025Article
- Development of an electrochemical sensor based on Ni-Bio-MOF and a molecular imprinted polymer for determination of diclofenac: electrochemical and DFT investigations.RSC advances · 2025Article
- Effectiveness of waste-derived MIL type MOFs in removing PFOA and PFAS pollutants for environmental remediation.Scientific reports · 2025Article
- Metal-organic frameworks as nanoplatforms for combination therapy in cancer treatment.Medical oncology (Northwood, London, England) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel metal-organic framework [MOFs], and 2-[benzo [
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.